LTFS
VNDA icon

Ladenburg Thalmann Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$1K – 5419
2019
Q1 		$1K Hold
50
– – ﹤0.01% 5119
2018
Q4 		$1K Sell
50
-559
-92% -$13.1K ﹤0.01% 5095
2018
Q3 		$14K Buy
+609
New +$12.4K ﹤0.01% 4117
2017
Q4 		– Sell
-1,134
Closed -$20K – 5125
2017
Q3 		$20K Buy
1,134
+609
+116% +$10.2K ﹤0.01% 3688
2017
Q2 		$9K Sell
525
-20,000
-97% -$288K ﹤0.01% 4090
2017
Q1 		$287K Buy
20,525
+334
+2% +$4.76K ﹤0.01% 1664
2016
Q4 		$322K Buy
20,191
+191
+1% +$3.07K ﹤0.01% 1504
2016
Q3 		$333K Hold
20,000
– – 0.01% 1425
2016
Q2 		$224K Hold
20,000
– – ﹤0.01% 1609
2016
Q1 		$167K Hold
20,000
– – ﹤0.01% 1729
2015
Q4 		$186K Hold
20,000
– – ﹤0.01% 1635
2015
Q3 		$226K Sell
20,000
-8,600
-30% -$105K ﹤0.01% 1409
2015
Q2 		$363K Hold
28,600
– – 0.01% 1224
2015
Q1 		$266K Sell
28,600
-575
-2% -$6.5K 0.01% 1383
2014
Q4 		$418K Hold
29,175
– – 0.01% 1010
2014
Q3 		$303K Hold
29,175
– – 0.01% 1008
2014
Q2 		$472K Hold
29,175
– – 0.01% 804
2014
Q1 		$474K Sell
29,175
-825
-3% -$11.7K 0.01% 745
2013
Q4 		$372K Sell
30,000
-1,500
-5% -$15.1K 0.01% 807
2013
Q3 		$345K Buy
31,500
+1,500
+5% +$16K 0.01% 806
2013
Q2 		$242K Buy
+30,000
New +$202K 0.01% 898

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VNDA Position: Q2 2019 in Review

Ladenburg Thalmann Financial Services sold out of Vanda Pharmaceuticals (VNDA) in Q2 2019, closing a stake of 50 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in VNDA in Q2 2013 and held it in 21 quarters. The position peaked at $474K in Q1 2014. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Vanda Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 50 Vanda Pharmaceuticals shares in Q2 2019, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Ladenburg Thalmann Financial Services's Vanda Pharmaceuticals position peaked at $474K in Q1 2014.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.